BACKGROUND: In the absence of definitive data about the natural history of DCIS the appropriateness of describing DCIS as cancer is controversial. METHODS: We conducted a survey amongst British Breast Group (BBG) members, to determine which descriptions of DCIS were deemed most accurate and appropriate. RESULTS: 54/73 (74%) attendees completed the survey: A majority (34/54; 63%) said they would be comfortable using the description that explained DCIS as abnormal cells in the milk ducts that had not spread into other breast tissue and which did not need urgent treatment as if it was breast cancer and this description was overall the most preferred (24/54; 44%). CONCLUSIONS: Little consensus exists regarding how best to explain low grade DCIS...
Management of low-risk ductal carcinoma in situ (DCIS) is controversial, with clinical trials curren...
As a result of mammographic detection, ductal carcinoma in situ (DCIS) is an increasing problem in b...
Abstract The terms ductal and lobular intraepithelial neoplasia (DIN and LIN) were introduced by Tav...
Ductal carcinoma in situ (DCIS) is a complex medical entity which presents challenges for the health...
Following the introduction of the National Health Service Breast Screening Programme (NHSBSP) in the...
Ductal carcinoma in situ of the breast is a non-obligate precursor of invasive breast cancer, and at...
BACKGROUND: Diagnostic agreement among pathologists is 84% for ductal carcinoma in situ (DCIS). Stud...
© 2019 John Wiley & Sons Ltd Aims: Ductal carcinoma in situ (DCIS) of the breast is a heterogeneou...
Importance: While the prevalence of ductal carcinoma in situ (DCIS) of the breast has increased subs...
The high proportion of ductal carcinoma in situ (DCIS) presented in mammographic screening and the r...
Ductal carcinoma in situ (DCIS) is a noninvasive breast cancer. While debate persists about its most...
Heterogenicity of breast ductal carcinoma in situ gives rise to opposing proposals concerning its tr...
Background: The incidence of ductal carcinoma in situ (DCIS) has increased substantially since the i...
The breast is the most common site of cancer in females in many parts of the world. Mammary carcinom...
INTRODUCTION: Ductal carcinoma in situ (DCIS) accounts for approximately 10% of all newly-diagnosed ...
Management of low-risk ductal carcinoma in situ (DCIS) is controversial, with clinical trials curren...
As a result of mammographic detection, ductal carcinoma in situ (DCIS) is an increasing problem in b...
Abstract The terms ductal and lobular intraepithelial neoplasia (DIN and LIN) were introduced by Tav...
Ductal carcinoma in situ (DCIS) is a complex medical entity which presents challenges for the health...
Following the introduction of the National Health Service Breast Screening Programme (NHSBSP) in the...
Ductal carcinoma in situ of the breast is a non-obligate precursor of invasive breast cancer, and at...
BACKGROUND: Diagnostic agreement among pathologists is 84% for ductal carcinoma in situ (DCIS). Stud...
© 2019 John Wiley & Sons Ltd Aims: Ductal carcinoma in situ (DCIS) of the breast is a heterogeneou...
Importance: While the prevalence of ductal carcinoma in situ (DCIS) of the breast has increased subs...
The high proportion of ductal carcinoma in situ (DCIS) presented in mammographic screening and the r...
Ductal carcinoma in situ (DCIS) is a noninvasive breast cancer. While debate persists about its most...
Heterogenicity of breast ductal carcinoma in situ gives rise to opposing proposals concerning its tr...
Background: The incidence of ductal carcinoma in situ (DCIS) has increased substantially since the i...
The breast is the most common site of cancer in females in many parts of the world. Mammary carcinom...
INTRODUCTION: Ductal carcinoma in situ (DCIS) accounts for approximately 10% of all newly-diagnosed ...
Management of low-risk ductal carcinoma in situ (DCIS) is controversial, with clinical trials curren...
As a result of mammographic detection, ductal carcinoma in situ (DCIS) is an increasing problem in b...
Abstract The terms ductal and lobular intraepithelial neoplasia (DIN and LIN) were introduced by Tav...